Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization

Area of Science:

• Cardiology
• Vascular Medicine
• Interventional Cardiology

Background:

• Coronary artery disease (CAD) is a major cause of death globally, despite recent declines in mortality.
• Atherosclerosis can lead to severe cardiac events including angina, myocardial infarction, and heart failure.
• Medical management focuses on slowing plaque progression and preventing rupture, while revascularization addresses flow-limiting stenosis.

Purpose of the Study:

• To review the role and benefits of revascularization in managing coronary artery disease.
• To evaluate the impact of percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG) on patient outcomes.
• To clarify the indications for revascularization in both acute and chronic coronary syndromes.

Main Methods:

• Review of existing literature on coronary artery disease management and revascularization strategies.
• Analysis of outcomes data comparing invasive (revascularization) versus conservative approaches.
• Evaluation of evidence for the benefits of PCI and CABG in different patient subgroups.

Main Results:

• Revascularization in acute coronary syndromes significantly reduces death and myocardial infarction compared to conservative care.
• In chronic stable CAD, revascularization shows benefits in symptom relief, quality of life, and exercise capacity, especially in extensive disease.
• Revascularization is particularly effective for patients with moderate-to-severe ischemia and extensive coronary artery disease.

Conclusions:

• Revascularization via PCI or CABG offers significant advantages for specific coronary artery disease patient populations.
• These procedures are valuable adjuncts to medical therapy, improving patient symptoms and survival.
• The decision for revascularization should be individualized based on disease extent and ischemia severity.